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Dysregulation of brain-derived neurotrophic factor (BDNF), behavioral inhibition
temperament (BI), and small hippocampal volume have been linked to anxiety disorders.
Individuals with BI show facilitated acquisition of the classically conditioned eyeblink
response (CCER) as compared to non-BI individuals, and a similar pattern is seen in
an animal model of BI, the Wistar-Kyoto (WKY) rat. The present study examined the role
of hippocampal BDNF in the facilitated delay CCER of WKY rats. Consistent with earlier
work, acquisition was facilitated in WKY rats compared to the Sprague Dawley (SD) rats.
Facilitated acquisition was associated with increased BDNF, TrkB, and Arc mRNA in the
dentate gyrus of SD rats, but learning-induced increases in BDNF and Arc mRNA were
significantly smaller in WKY rats. To determine whether reduced hippocampal BDNF in
WKY rats was a contributing factor for their facilitated CCER, BDNF or saline infusions
were given bilaterally into the dentate gyrus region 1 h prior to training. BDNF infusion
did not alter the acquisition of SD rats, but significantly dampened the acquisition of
CCER in the WKY rats, such that acquisition was similar to SD rats. Together, these
results suggest that inherent differences in the BDNF system play a critical role in the
facilitated associative learning exhibited by WKY rats, and potentially individuals with BI.
Facilitated associative learning may represent a vulnerability factor in the development of
anxiety disorders.
Keywords: hippocampus, dentate gyrus, TrkB, Arc, Wistar-Kyoto rat
Introduction
Anxiety is the most commonly treated and prescribed for psychiatric condition in today’s society.
Determiningwho is susceptible to developing anxiety disorders and how these vulnerabilities impact
treatment efficacy is currentlly an active area of research. Individual differences play a crucial role in
whether a person develops an anxiety disorder or not. Epidemiologic studies indicate that exposure
to early childhood trauma and chronic stress increases one’s risk to developing anxiety disorders,
whereas a behaviorally inhibited temperament, a small hippocampal volume, and more recently,
dysfunction of hippocampal brain-derived neurotrophic factor (BDNF) are associated with inherent
vulnerabilities. While various risk or vulnerability factors have been identified, the mechanisms by
which they confer vulnerability are still unknown (1, 2).
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Brain-derived neurotrophic factor is a neurotrophin that influ-
ences cell growth, cell differentiation, and synaptic modifica-
tion (3, 4) and is highly expressed in the developing and adult
hippocampus (5–8). Recently, a single nucleotide polymorphism
(SNP) of the coding region of the BDNF gene (Val66Met) has
been identified as a risk factor for anxiety disorders, includ-
ing post-traumatic stress disorder (PTSD) (9, 10). The genetic
variation resulting in a substitution of a valine to a methion-
ine at codon 66 restricts intra-cellular trafficking and activity-
dependent release of hippocampal BDNF. Individuals with the
met allele have reduced hippocampal volume (11–14), deficits in
hippocampal-dependent memory (15, 16), and altered responses
to emotional stimuli (17, 18). Given that BDNF is released in
an activity-dependent manner, BDNF may be a key factor in
experience-dependent vulnerability to psychiatric disorders (19).
The link between an abnormal BDNF system and anxiety vul-
nerabilitymay be through the hippocampus. A small hippocampal
volume and impaired hippocampal-dependent learning are likely
pre-existing conditions in those that develop PTSD, suggesting
that a dysfunctional hippocampus is a vulnerability factor for
PTSD (2, 20). PTSD patients with the Val66Met SNP were less
responsive to cognitive behavioral therapy than those without
the SNP (21), implicating an involvement of BDNF in extinction
learning. In humans, abnormally low levels of BDNF are associ-
ated with a smaller hippocampal volume (22) andmood disorders
including obsessive-compulsive disorder (23), and depression
(24). The link between low levels of hippocampal BDNF and
mood disorders has been dubbed the neurotrophin hypothesis,
whereby enhancement in BDNF signaling is observed in the
hippocampus after administration of antidepressants (25, 26).
These results suggest an association between dysfunction of the
BDNF system, small hippocampal volume, hippocampal learning
impairment, and risk to develop mood disorders in humans.
Similar to humans, BDNF is important for normal function of
the hippocampus in animals. A low amount of BDNF is associated
with a smaller hippocampal volume (22). BDNF is important for
adult neurogenesis in the dentate gyrus (27), and reduced BDNF
impairs spatial memory and extinction of fear memories (28).
Anxiety-related behaviors are also enhanced in the transgenic
mouse reproducing the Val66Met SNP (Met66 allele) of humans
(9, 29). These mice have smaller hippocampi, reduced activity-
dependent secretion of BDNF, dendritic shrinkage in the DG,
and impaired extinction of fear conditioning compared to wild-
type mice. The Val66Met polymorphism has also been linked to
reductions in NMDA transmission, and resistance to selective
serotonin reuptake inhibitor (SSRI)-induced LTP and neuroge-
nesis in the dentate gyrus (30, 31). Thus, low levels of BDNF
protein or impaired BDNF release via a Val66Met SNP results in
a smaller hippocampus, abnormal fear extinction, anxiety-related
behaviors, and reduced efficacy of antidepressants.
Behavioral inhibition is a temperament characterized by with-
drawal from and avoidance of novel social and non-social inter-
actions (32) and is a vulnerability factor for developing anxiety
disorders (33–35). The neurobiology of inhibited temperament
has been heavily linked to alterations in amygdala, prefrontal cor-
tex, and basal ganglia (36). Although less well-studiedwith respect
to inhibited temperament, the hippocampus also demonstrates
altered function in individuals with inhibited temperament (36).
In particular, the interaction of the risk factor of childhood mal-
treatment and the inherent vulnerability of inhibited tempera-
ment was associatedwith increased activation of the hippocampus
to novel faces with the strongest correlation in individuals who
developed an anxiety disorder (37). Importantly, the activity in the
amygdala to novel faces did not correlate to childhood maltreat-
ment, suggesting the amygdala and hippocampus may contribute
differently to inhibited temperament.
Reflective of altered hippocampal function in behavioral inhi-
bition is the facilitation of non-hippocampal-dependent asso-
ciative learning in individuals with inhibited temperament. The
delay paradigm of classical conditioning of the eyeblink response
(CCER) does not require the hippocampus (38), in contrast to
the trace paradigm of CCER. In fact, hippocampal damage can
facilitate acquisition of delay CCER (39), whereas similar dam-
age impairs acquisition of trace CCER (40). Support that inhib-
ited temperament is associated with hippocampal dysfunction is
the finding that individuals scoring high on behavioral inhibi-
tion scales acquire delay classical conditioning faster than non-
inhibited individuals (41–44). Similarly, the Wistar-Kyoto (WKY)
rat, an animalmodel of behavioral inhibition, demonstrated facili-
tated acquisition of delay CCER (45). Thus, behaviorally inhibited
temperament is associated with facilitated associative learning
that may underlie anxiety vulnerability (46).
The WKY rat demonstrates inhibited temperament as evi-
denced by reduced exploration in the open-field test (47, 48)
and freezing behavior in response to novel social and non-social
stress (48, 49). Additionally,WKY rats are hyper-sensitive to stress
(50–52) and acquire active avoidance more rapidly, to a greater
extent, and more persistently than Sprague Dawley (SD) rats (53,
54). Avoidance is a common feature of all anxiety disorders, and
greater persistent avoidant responding is reminiscent of individ-
uals with anxiety disorders (55). The WKY rat has a smaller
hippocampal volume compared to the non-inhibited rat strains
(56), is impaired in hippocampal-dependent learning tasks (49,
57), and behaves similarly to rats with hippocampal damage (56,
58). The BDNF system may be abnormal in the WKY rat; serum
BDNF levels in WKY, but not SD, rats decreased following stress
(59), and SSRIs are less effective inWKY rats compared to SD rats
in the Porsolt Swim test (60), similar to mice with low levels of
BDNF or Val66Met SNP.
In summary, an impaired BDNF system is a vulnerability factor
for anxiety disorders and affects normal hippocampal function.
Inhibited temperament is also a vulnerability factor for anxiety
disorders and is associated with facilitated acquisition of delay
CCER in humans and animals. The present study was conducted
to determine whether an impaired hippocampal BDNF system
underlies facilitated CCER that is associated with inhibited tem-
perament and anxiety vulnerability.
Materials and Methods
Subjects were male SD and WKY rats obtained from Charles
River, Kingston, NY, USA. They were approximately 3months in
age at the time of testing and maintained on a 12-h light/dark
cycle with onset of light at 0700 h. All animals were tested during
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the light phase. Rats were housed individually in standard cages
(16.5 in 8.5 in 8 in) with ad lib access to food and water and
were acclimated upon arrival for at least 5 days prior to experimen-
tation. All experiments were carried out in accordance with the
Institutional Animal Care and Use Committee of the East Orange,
New Jersey Health Care System, Veterans Affairs Medical Center.
Surgery
Sprague Dawley and WKY rats were anesthetized with Nembutal
(50mg/kg i.p.), and supplemented as necessary. Guide cannulas
(26 g, Plastics One, Roanoke, VA, USA) were implanted bilaterally
(4mm posterior and 2.5mm lateral from bregma, and  3.1mm
ventral from brain surface) directed at the dentate gyrus region of
the hippocampus. Each guide cannula was fixed to skull screws
(stainless steel) using dental acrylic cement. A stylet was inserted
into the guide cannula to keep the cannula patent.
Electrodes were implanted into the periorbital muscles for
eyeblink conditioning. Four Teflon-coated, stainless steel wires
(75µm diameter, AM Systems) had the insulation stripped from
one end that was inserted into the muscle. The other end of the
wire was inserted into a plastic connector (Cannon Centi-loc, ITT
Cannon, Santa Ana, CA) that was glued to three to four skull
screws using dental acrylic. Two wires were used to record elec-
tromyography (EMG) and the other two wires delivered electrical
stimulation.
Following the surgical procedure, sutures were used as needed
and rats were post-operatively treated with flunixin meglumine
(2.5mg/kg, s.c.) for 2 days. Rats were allowed at least 4 days to
recover from surgery.
Classical Conditioning of the Eyeblink Response
Eyeblink conditioning was conducted in a sound-attenuated
chamber (27 cm 29 cm 43 cm) with a viewing window (Med
Associates, St. Albans, VT, USA). The EMG signals were recorded
from electrodes that were connected to a differential AC amplifier
through a cable attached to the plastic connector on the rat’s head.
EMG signals were filtered (300–500Hz) and amplified (10,000X,
A-M Systems Model 1700, Everett, WA, USA). Electrical stim-
ulation of the periorbital muscles was delivered by a stimulus
isolation unit (Coulbourn Instruments, Whitehall, PA, USA). A
computer equipped with an A/D board and LabView software
(National Instruments, Austin, TX, USA) controlled stimuli pre-
sentation and recording of EMG signals digitized at a sampling
rate of 1000Hz. One day prior to conditioning, freely moving rats
were habituated to the apparatus for 30min. During habituation,
EMG signal quality was determined. Rats were conditioned for 1
or 2 days following habituation.
Rats were conditioned using a delay conditioning paradigm.
Rats received 100 conditional stimulus (CS)-unconditional stim-
ulus (US) paired trials per day. An auditory stimulus (500ms,
82 dB white noise, 10ms rise/fall) served as the CS. Electrical
stimulation of the periorbital muscles (10V, 10ms) served as the
US. CS andUS co-terminated. The inter-trial interval (ITI) ranged
from 15 to 35 s with an average of 25 s.
Electromyography was analyzed to determine the occurrence
of eyeblinks using a custom designed script in S-Plus (version
6.1, Insightful Corporation, Seattle, WA, USA). For each trial, the
250ms prior to the presentation of the CS was used as a baseline
for each trial. An eyeblink, conditioned response (CR), was des-
ignated when the EMG activity exceeded a threshold amplitude
following the CS onset and prior to the US onset. Threshold
amplitude was equal to the mean amplitude of the baseline plus
four standard deviations of the baseline activity. Any response
recorded during the first 30ms of the CS onset (250–280ms) was
not counted as a CR, as this time frame typically indicates an
orienting response and represents less than 10% of eyeblinks. To
evaluate the rate of acquisition, trials were grouped into five blocks
of 20 trials per day. Analysis of variance (ANOVA) with repeated
measures was used to analyze CR.
BDNF Administration
For animals receiving infusions prior to eyeblink conditioning, an
infusion cannula (33 g, Plastics One, Roanoke, VA, USA) attached
to a Hamilton syringe via polyethylene tubing (PE 50, Becton
Dickinson, Sparks,MD,USA)was inserted into the guide cannula.
Sterile saline (0.5µl) or rhBDNF (0.5µg/0.5µl; R&D Systems,
Minneapolis, MN) was administered (0.1µl/min) into the dentate
gyrus region of the hippocampus. After drug administration, the
infusion cannula was allowed to remain in place for 5min, and
then removed and replaced with a stylet. Infusions were given
approximately 45min (40–50min range) prior to the start of the
eyeblink conditioning session. Saline or BDNF was infused prior
sessions 1 and 2 of conditioning.
Tissue Extraction
Animals for RT-PCR analysis were sacrificed and the hippocam-
pus was extracted approximately 1 h after Day 1 of eyeblink condi-
tioning. Because BDNF levels fluctuate throughout the day, tissue
collection was confined to 3 h after the onset of the light cycle,
approximately between 10:00 a.m. and 1:00 p.m. After decapita-
tion and rapid removal of the brain, CA1, CA3, and dentate gyrus
regions of both hippocampi were dissected rapidly on ice, placed
in microcentrifuge tubes, and stored in dry ice. Net wet tissue
weight of the tissue was recorded. Samples were stored at  80°C
pending analysis.
RT-PCR
mRNA for BDNF, TrkB (high affinity BDNF receptor), and
the immediate early gene Arc (activity-regulated cytoskeleton-
associated protein) was measured using RT-PCR. Total RNA
was isolated from the dentate gyrus by submerging in Trizol
reagent and adding Zirconium disruption beads (Thomas Scien-
tific, Swedesboro, NJ, USA). Supernatant was further processed
and DNase treated as per manufacturer’s instructions (Direct-zol
RNA mini-prep, Zymo Research, Irvine, CA, USA). The RNA
concentration was quantified using the NanoDrop Spectropho-
tometer (NanoDrop, Wilmington, DE, USA). Total RNA was
reverse transcribed by first denaturing 1µg sample and 1µl of
300 ng/µL RT primer at 65°C for 5min and then chilling on ice.
Next, 6µl of 5 Superscript Buffer, 1.5µl 0.1MDTT, 1.5µl 10mM
dNTPs, 1µl Superase In, and 1µl Superscript III (Life Technolo-
gies, Invitrogen, Carlsbad, CA, USA) were added to the samples
and incubated at 25°C for 10min, followed by 45°C for 2 h. The
RT reaction was terminated by heating at 70°C for 15min and
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the cDNA stored at  20°C. RT-PCR was performed using Roche
Lightcycler® containing 3µl of cDNA, 10µl Taqman Universal
PCR master mix, 1µl of Taqman probe (Bdnf Taqman Probe,
Rn02531967; Ntrk2 Taqman Probe, Rn01441749_ml; Arc Taq-
man Probe, Rn00571208_gl; 18S Taqman Probe, hs99999901_s1;
Applied Biosystems, Grand Island, NY, USA), 1µl of Bovine
Serum Albumin (2.5mg/mL; BioFire, Salt Lake City, UT, USA),
and 5µl dH20.
The cycle threshold (CT) value was determined for each probe.
Data for each target gene were assayed in duplicate and averaged,
target values were normalized to the mean of the housekeeping
gene 18S ribosomal RNA, which showed the lowest amount of
variability across strain and treatment. Fold differences between
samples for each gene product were calculated as follows:
2^ (Sample with highest CT value for target gene-individualsample’s CT value for target gene)
2^ (Sample with highest CT value for 18S rRNA-individualsample’s CT value for 18S rRNA)
Statistical Analysis
Statistical analyses were conducted using Statistical Package for
the Social Sciences (SPSS for Windows, Version 16, SPSS, Inc.,
Chicago, IL, USA). All results were considered significant at
α= 0.05. Behavioral data for mRNA analysis were evaluated
with a mixed design ANOVA for CR probability with blocks as
a within-subject factor and strain as a between-subject factor.
Average CR probability was calculated for blocks consisting of
20 trials, resulting in five blocks per session. Behavioral data
for BDNF administration had a similar experimental design,
but with the addition of treatment as a between subjects factor.
mRNA data were analyzed using an ANOVA with strain and
conditioning as between subjects factors. Separate analyses were
conducted for BDNF, TrkB, and Arc mRNA in each hippocampal
subregion. Only significant (p< 0.05) and trending (p< 0.1)
results are reported.
Results
Learning-Induced Changes in Hippocampal
BDNF, TrkB, and Arc mRNA
Behavior
Sprague Dawley (n= 7) andWKY (n= 8) rats were trained in one
session of delay classical conditioning of the eyeblink response
followed by sacrifice for assessment of hippocampal BDNF, TrkB,
and Arc mRNA. Due to problems with EMG recording, 1 SD and
2WKY rats could not be evaluated for behavior; these rats showed
clear eyeblink to periorbital electrical stimulation US and should
demonstrate classical conditioning similar to other rats. There-
fore, all rats were included in the mRNA analysis. Acquisition of
classical conditioning was significantly faster and performed to a
greater degree in WKY rats compared to SD rats, main effect of
strain [F(1, 10)= 5.02, p< 0.05] (Figure 1), replicating previous
results (45). Overall, general learning was demonstrated by a
main effect of block [F(4, 40)= 8.38, p< 0.001]. No interaction
between block and strain was observed. Ninety to one hundred
and twenty minutes following the conditioning sessions, rats were
FIGURE 1 | Strain differences in classical eyeblink conditioning.
Wistar-Kyoto (WKY) and Sprague Dawley (SD) rats were trained in delayed
classical conditioning of the eyeblink response. A session consisted of five
blocks of 20 trials. WKY rats acquired eyeblink conditioning significantly faster
and to a greater extent than SD rats, as demonstrated by higher levels of
conditioned responses.
sacrificed and the hippocampus removed, subdivided, and stored
for subsequent analysis by qRT-PCR.
Brain-Derived Neurotrophic Factor
In the DG, learning increased BDNF mRNA in SD to a greater
extent than WKY, as demonstrated by a strain conditioning
interaction [F(1,19)= 5.06, p< 0.05] (Figure 2). BDNF mRNA
was increased by conditioning, main effect of conditioning
[F(1,19)= 15.4, p< 0.001], and both strains showed learning-
induced increases [SD: t(9)= 3.17, p< 0.05; WKY: t(10)= 2.4,
p< 0.05]. In CA3, conditioning enhanced BDNF mRNA
[F(1,20)= 12.94, p< 0.005] with a trend for upregulation in
CA1 [F(1,19)= 3.57, p= 0.074], but these changes did not differ
between strains.
TrkB Receptor
In all three subregions of the hippocampus, rats in the classical
conditioning group had higher TrkB mRNA than sham rats [DG:
F(1,19)= 8.09, p< 0.01; CA3: F(1,20)= 10.32, p< 0.005; CA1:
F(1,20)= 6.24, p< 0.05] (Figure 2). However, TrkB mRNA did
not differ between strains in any of the hippocampal subregions.
Arc
In the DG, classical conditioning upregulated Arc mRNA
[F(1,19)= 4.67, p< 0.05] (Figure 2). Conditioning increased Arc
mRNA to a greater extent in SD rats compared toWKY rats, main
effect of strain [F(1,19)= 4.94, p< 0.05], strain conditioning
interaction [F(1,19)= 3.04, p= 0.097]. Arc mRNA did not differ
between strains or conditioning groups in the CA1 and CA3
regions.
Effects of Intrahippocampal BDNF on Delay
Eyeblink Conditioning Acquisition
Following CCER, up-regulation of BDNF and Arc mRNA in
the DG was blunted in the WKY rats compared to SD rats.
Therefore, the effects of administering BDNF into the DG at
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FIGURE 2 | Learning-induced increases in BDNF, TrkB, and Arc
mRNA differed between SD and WKY rats. Following a single session
of classical conditioning of the eyeblink response (CCER), the hippocampal
subregions were dissected, and BDNF (left), TrkB (middle), and Arc (right)
mRNA was assessed in the dentate gyrus (upper), CA3 (middle), and CA1
(lower) subregions of the hippocampus. BDNF mRNA was significantly
increased following acquisition of CCER in the dentate gyrus and CA3. In
CA1, the main effect of learning did not reach significance (p=0.074).
Moreover, learning-induced changes in the dentate gyrus of WKY rats were
significantly smaller than that in SD rats. By contrast, learning-induced
changes of BDNF mRNA in CA3 were similar between strains. Learning
caused increases of TrkB mRNA in all hippocampal subregions and
increases were similar between SD and WKY rats. Finally, acquisition of
CCER increased Arc mRNA only in the dentate gyrus, but not CA3 or CA1.
The changes in Arc mRNA in the dentate gyrus were significantly smaller in
the WKY rat compared to SD rat.
the time of CCER were evaluated in both strains. Rats (SD-
saline, n= 7; SD-BDNF, n= 8; WKY-saline, n= 9; WKY-BDNF,
n= 9) were administered and conditioned in two sessions. Only
animals that had reliable EMG signals on both days of train-
ing were used in the analysis. CRs increased as a consequence
of training in all rats for days 1 and 2, main effect of block
[F(4, 116)= 8.148, p< 0.001] and main effect of day [F(1,
29)= 24.28, p< 0.001] (Figure 3). Similar to previous studies,
WKY rats acquired faster than SD rats, main effect of strain [F(1,
29)= 12.48, p< 0.001]. Importantly, BDNF infusion into the DG
affectedWKYbut not SD rats, strain treatment interaction [F(1,
29)= 4.972, p< 0.05]. Neither themain effect of treatment nor the
block strain treatment interaction was significant.
Given the significant strain treatment interaction, further
analysis was conducted on the effects of BDNF in each strain. In
SD rats, BDNF treatment did not alter the acquisition of delay
CCER, as neither the main effect nor interactions involving treat-
ment were significant. By contrast, WKY rats were significantly
slowed in acquisition by BDNF administration, main effect of
treatment [F(1, 16)= 8.7, p< 0.01] and treatment day block
interaction [F(4, 64)= 2.72, p< 0.05].
Discussion
The present study utilized the WKY rat to investigate the role of
hippocampal BDNF in the facilitated associative learning that is
observed in behaviorally inhibited individuals. The hippocampus
was the focus of this study because it contains a high amount of
BDNF (5–8), and dysfunction of hippocampus andBDNF systems
both represent vulnerabilities for developing anxiety disorders (2,
9, 10, 20, 29). Furthermore, hippocampal damage leads to facili-
tated acquisition of delay CCER (39), similar to high behaviorally
inhibited humans (41–44) and animals (45). In agreement with
previous findings, the present study found WKY rats acquired
delay CCER faster and to a greater degree than SD rats. Acquisi-
tion ofCCERwas associatedwith increasedBDNFandArcmRNA
in the DG and CA3 of the hippocampus. Importantly, WKY rats
had smaller increases than SD rats in the DG. TrkB mRNA was
also increased following CCER in all hippocampal subregions, but
these changes did not differ between strains. The smaller learning-
induced changes of BDNF and Arc mRNA inWKY rats suggested
that the lack of BDNF and resultant hippocampal dysfunction
in this rat strain may be responsible for facilitated CCER. To
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FIGURE 3 | Intrahippocampal BDNF normalized classical conditioning
of the eyeblink response in the WKY rat. BDNF was administered into the
dentate gyrus of SD and WKY rats prior to each of two sessions of eyeblink
conditioning. Saline-treated WKY rats acquired eyeblink conditioning
significantly faster and to a greater extent than saline-treated SD rats, as
demonstrated by more conditioned responses. BDNF administration in WKY
rats slowed classical eyeblink conditioning to a level similar to that observed in
SD rats. BDNF treatment did not alter classical conditioning in SD rats.
test this hypothesis, exogenous BDNF was administered into the
DG of SD and WKY rats prior to eyeblink conditioning sessions.
Intrahippocampal BDNF slowed CCER acquisition of WKY rats
to a level similar to SD rats. By contrast, BDNF infusions did not
alter CCER acquisition in SD.
Brain-derived neurotrophic factor is important for
hippocampal-dependent learning (61, 62). With respect to
classical conditioning, contextual fear conditioning enhanced
the number of CA1 neurons expressing BDNF immunoreactivity
(63). BDNFheterozygous knockoutmicewere poorer in acquiring
contextual but not cued fear conditioning, suggesting a differential
action of BDNF on hippocampal-dependent and -independent
forms of classical conditioning (64). In the present study, acqui-
sition of a hippocampal-independent form of CCER increased
BDNF mRNA in all three subregions of the hippocampus.
An increase in BDNF causes somatodendritic expression of Arc
mRNA in the dentate gyrus (65). Arc, an immediate early gene,
is one of the first genes transcribed after receiving extracellular
signaling and is implicated in learning and memory. The induc-
tion of Arc enlarges dendrites, impacts dendritic structure and
organization, is activated in dendrites in an NMDA-dependent
manner (66), and is increased several hours post-BDNF infu-
sion (67). Arc was increased in the hippocampus following
hippocampal-dependent trace and contextual fear conditioning,
but not after hippocampal-independent delay fear condition-
ing (68). The lack of change in Arc following hippocampal-
independent delay fear conditioning contrasts with results of the
present study, which showed increases in Arc mRNA follow-
ing hippocampal-independent delay CCER. In the present study,
the increase in Arc mRNA was only observed in the DG and
not in the other hippocampal subregions. Therefore, the lack of
change in Arc following fear conditioning may be due to dilution
of the Arc changes in DG by other hippocampal subregions,
although differences between fear conditioning and CCER cannot
be entirely ruled out either.
AlthoughWKYrats acquired delayCCER faster and to a greater
extent than SD rats, they had smaller increases in BDNF and Arc
mRNA than SD rats. Blunted changes in BDNF and Arc mRNA
observed in WKY rats can be interpreted as poorer hippocampal
function, and is supported by impaired hippocampal synaptic
plasticity in WKY rats (56). Thus, our results support the view
that damage or dysfunction of the hippocampus can lead to better
acquisition of delay CCER (39).
Brain-derived neurotrophic factor administration enhances
various forms of learning and memory (62). Infusion of BDNF
into the hippocampus enhanced water maze reversal learning and
reduced anxiety-like behavior in an elevated plusmaze, suggesting
that hippocampal BDNF improve hippocampal-dependent learn-
ing and reduce anxiety (69). Additionally, hippocampal infusions
of BDNF enhanced contextual fear conditioning in BDNF het-
erozygous knockout mice (64) and transgenic mice expressing
active CREB or their wild-type counterparts (70). While most
evidence is that BDNF enhances hippocampal-dependent forms
of learning, the effect of hippocampal BDNF administration on
hippocampal-independent learning has not been addressed. The
present study shows that administration of BDNF into the hip-
pocampus ofWKY rats slowed acquisition of delayCCER to a level
equivalent to that demonstrated by SD rats. Thus, hippocampal
BDNF administration can result in poorer acquisition on some
forms of learning and in some rat strains. In this regard, the
delay CCER paradigmmay be a special case because hippocampal
damage can facilitate acquisition (39).
The results of the present study provide a potential link between
three anxiety vulnerabilities: BDNFdysfunction, small hippocam-
pal volume and impaired function, and behavioral inhibition.
BDNF dysfunction can lead to reduced hippocampal volume and
impaired hippocampal-dependent learning. In humans, abnor-
mally low levels of BDNF are associated with a smaller hippocam-
pal volume (22). However, the effect of the BDNF Val66Met SNP
on hippocampal volume in humans is unclear (71), although an
association between reduced hippocampal volume and the inter-
action of Val66Met SNP with environmental factors (childhood
maltreatment) is growing (72, 73). Individuals with the Val66Met
SNP have impairments in learning and memory that are gener-
ally considered to be hippocampal dependent (74). Mice with
the Val66Met SNP have smaller hippocampi, reduced activity-
dependent secretion of BDNF, dendritic shrinkage in the DG, and
impaired extinction of fear conditioning compared to wild-type
mice (9, 29). It is possible that BDNF and hippocampal dysfunc-
tion represent the same vulnerability. Early childhood trauma or
chronic stress is a risk factor for anxiety disorders. One of the
structures most affected by chronic stress is the hippocampus, due
to the density of glucocorticoid receptors (GRs) and its involve-
ment in regulating the HPA axis (75–77). One mechanism by
which stress has a negative impact on hippocampal morphology
and function is by decreasing hippocampal BDNF, resulting in
decreased neurogenesis, dendritic atrophy, and impaired cogni-
tion (3, 4, 28, 78–80). These stress-induced reductions of BDNF
may relate to the reductions of BDNF protein and hippocampal
volume in some patients without Val66Met genotype.
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While there is an abundance of evidence associating BDNF
and hippocampus volume and function, links between inhib-
ited temperament and BDNF or hippocampal dysfunction has
been sparse. Individuals with inhibited temperament have abnor-
mal hippocampal processing of novel stimuli in humans (37,
81). Interestingly, activation of the hippocampus to novel
faces was most strongly associated with inhibited tempera-
ment and childhood maltreatment (37). As described above,
childhood maltreatment and chronic stress are associated with
smaller hippocampal volume and hippocampal dysfunction.
In animal studies, the behaviorally inhibited WKY rat has
a smaller hippocampus than non-inhibited rat strains (56),
impaired hippocampal synaptic plasticity (56), and poorer per-
formance on hippocampal-dependent learning procedures (49,
57). The WKY rat also behaves similarly to rats with hip-
pocampal damage (56, 58). Thus, there is little evidence to
link inhibited temperament with smaller hippocampus or BDNF
dysfunction, except for the animal work. However, inhibited
temperament may interact with either BDNF/hippocampal
dysfunction to exacerbate vulnerability to develop anxiety
disorders.
In summary, BDNF dysfunction in the hippocampus was
observed in an animal model of behavioral inhibition, the WKY
rat. This dysfunction was related to facilitated acquisition of
hippocampal-independent associative learning. Gain of function
experiments by administering BDNF into the hippocampus of
WKY rats “normalized” associative learning. The results suggest
a possible mechanism by which hippocampal dysfunction and
behavioral inhibition leads to pathological associative learning
and vulnerability to develop anxiety disorders.
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